Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 41% ± 17% | |
glutamatergic neuron | 10 studies | 51% ± 17% | |
GABAergic neuron | 9 studies | 45% ± 16% | |
smooth muscle cell | 8 studies | 31% ± 10% | |
oligodendrocyte | 7 studies | 28% ± 12% | |
interneuron | 6 studies | 33% ± 15% | |
adipocyte | 6 studies | 31% ± 17% | |
mesothelial cell | 6 studies | 43% ± 17% | |
neuron | 5 studies | 33% ± 8% | |
amacrine cell | 5 studies | 43% ± 26% | |
pericyte | 5 studies | 27% ± 14% | |
connective tissue cell | 5 studies | 44% ± 22% | |
endothelial cell | 4 studies | 38% ± 20% | |
epithelial cell | 4 studies | 44% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 7% | |
myofibroblast cell | 4 studies | 31% ± 8% | |
GABAergic interneuron | 3 studies | 50% ± 4% | |
GABAergic amacrine cell | 3 studies | 49% ± 8% | |
glycinergic amacrine cell | 3 studies | 26% ± 10% | |
retinal ganglion cell | 3 studies | 34% ± 16% | |
Schwann cell | 3 studies | 26% ± 7% | |
adventitial cell | 3 studies | 56% ± 12% | |
ciliated cell | 3 studies | 26% ± 6% | |
astrocyte | 3 studies | 37% ± 23% | |
renal alpha-intercalated cell | 3 studies | 67% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 3508.73 | 241 / 245 | 92% | 7.72 | 463 / 502 |
lung | 100% | 10796.83 | 577 / 578 | 80% | 7.14 | 920 / 1155 |
thymus | 96% | 2991.83 | 630 / 653 | 81% | 11.13 | 492 / 605 |
breast | 93% | 2170.96 | 425 / 459 | 82% | 6.48 | 920 / 1118 |
ovary | 72% | 1045.19 | 129 / 180 | 77% | 6.05 | 332 / 430 |
kidney | 84% | 1511.31 | 75 / 89 | 61% | 8.95 | 546 / 901 |
uterus | 99% | 4182.51 | 169 / 170 | 44% | 4.70 | 200 / 459 |
adrenal gland | 100% | 4559.45 | 258 / 258 | 38% | 4.83 | 88 / 230 |
bladder | 100% | 4113.33 | 21 / 21 | 33% | 2.01 | 168 / 504 |
esophagus | 78% | 4450.29 | 1120 / 1445 | 40% | 2.73 | 74 / 183 |
stomach | 70% | 2283.27 | 253 / 359 | 42% | 3.56 | 120 / 286 |
intestine | 81% | 2546.01 | 781 / 966 | 28% | 2.00 | 147 / 527 |
skin | 65% | 2375.57 | 1171 / 1809 | 43% | 3.64 | 203 / 472 |
brain | 60% | 1097.32 | 1576 / 2642 | 40% | 3.24 | 285 / 705 |
spleen | 100% | 3238.14 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 2768.38 | 1305 / 1335 | 0% | 0 | 0 / 0 |
adipose | 95% | 2059.47 | 1138 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 12% | 124.28 | 39 / 328 | 82% | 8.18 | 146 / 178 |
heart | 66% | 1059.40 | 566 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 33% | 1.26 | 15 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.65 | 6 / 29 |
liver | 1% | 10.46 | 3 / 226 | 19% | 1.17 | 78 / 406 |
muscle | 16% | 155.50 | 125 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001657 | Biological process | ureteric bud development |
GO_0030837 | Biological process | negative regulation of actin filament polymerization |
GO_0014912 | Biological process | negative regulation of smooth muscle cell migration |
GO_0050772 | Biological process | positive regulation of axonogenesis |
GO_0050929 | Biological process | induction of negative chemotaxis |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0035385 | Biological process | Roundabout signaling pathway |
GO_0043116 | Biological process | negative regulation of vascular permeability |
GO_0070100 | Biological process | negative regulation of chemokine-mediated signaling pathway |
GO_0071676 | Biological process | negative regulation of mononuclear cell migration |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0071504 | Biological process | cellular response to heparin |
GO_0090260 | Biological process | negative regulation of retinal ganglion cell axon guidance |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0002689 | Biological process | negative regulation of leukocyte chemotaxis |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0021834 | Biological process | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration |
GO_0021972 | Biological process | corticospinal neuron axon guidance through spinal cord |
GO_0048846 | Biological process | axon extension involved in axon guidance |
GO_0050919 | Biological process | negative chemotaxis |
GO_0010593 | Biological process | negative regulation of lamellipodium assembly |
GO_0021836 | Biological process | chemorepulsion involved in postnatal olfactory bulb interneuron migration |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0003184 | Biological process | pulmonary valve morphogenesis |
GO_0008045 | Biological process | motor neuron axon guidance |
GO_0010596 | Biological process | negative regulation of endothelial cell migration |
GO_0071672 | Biological process | negative regulation of smooth muscle cell chemotaxis |
GO_0031290 | Biological process | retinal ganglion cell axon guidance |
GO_0090027 | Biological process | negative regulation of monocyte chemotaxis |
GO_0051058 | Biological process | negative regulation of small GTPase mediated signal transduction |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0051414 | Biological process | response to cortisol |
GO_0061364 | Biological process | apoptotic process involved in luteolysis |
GO_0090024 | Biological process | negative regulation of neutrophil chemotaxis |
GO_0007411 | Biological process | axon guidance |
GO_0090288 | Biological process | negative regulation of cellular response to growth factor stimulus |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0008201 | Molecular function | heparin binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005095 | Molecular function | GTPase inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0048495 | Molecular function | Roundabout binding |
GO_0043237 | Molecular function | laminin-1 binding |
GO_0043394 | Molecular function | proteoglycan binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLIT2 |
Protein name | Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Slit guidance ligand 2 Uncharacterized protein SLIT2 |
Synonyms | SLIL3 |
Description | FUNCTION: Thought to act as molecular guidance cue in cellular migration, and function appears to be mediated by interaction with roundabout homolog receptors. During neural development involved in axonal navigation at the ventral midline of the neural tube and projection of axons to different regions. SLIT1 and SLIT2 seem to be essential for midline guidance in the forebrain by acting as repulsive signal preventing inappropriate midline crossing by axons projecting from the olfactory bulb. In spinal cord development may play a role in guiding commissural axons once they reached the floor plate by modulating the response to netrin. In vitro, silences the attractive effect of NTN1 but not its growth-stimulatory effect and silencing requires the formation of a ROBO1-DCC complex. May be implicated in spinal cord midline post-crossing axon repulsion. In vitro, only commissural axons that crossed the midline responded to SLIT2. In the developing visual system appears to function as repellent for retinal ganglion axons by providing a repulsion that directs these axons along their appropriate paths prior to, and after passage through, the optic chiasm. In vitro, collapses and repels retinal ganglion cell growth cones. Seems to play a role in branching and arborization of CNS sensory axons, and in neuronal cell migration. In vitro, Slit homolog 2 protein N-product, but not Slit homolog 2 protein C-product, repels olfactory bulb (OB) but not dorsal root ganglia (DRG) axons, induces OB growth cones collapse and induces branching of DRG axons. Seems to be involved in regulating leukocyte migration. . |
Accessions | ENST00000504154.6 [O94813-1] F5H0U4 ENST00000508824.1 ENST00000273739.9 ENST00000509941.1 H0Y968 ENST00000503823.5 [O94813-3] H0Y9Z6 ENST00000511508.5 X6R3P0 E9PCX4 Q4W5K2 Q4W5N0 ENST00000622093.4 A0A087WYV5 O94813 ENST00000503837.5 [O94813-2] ENST00000512993.1 |